NEW YORK (GenomeWeb News) — An arbitration panel overseeing a legal skirmish between Digene and Roche has allowed Gen-Probe to participate in the proceeding, Digene said today.
In the proceeding, Digene hopes to prove that a February 2005 supply and license agreement between Roche and Gen-Probe was an illegal sublicense under a 1990 cross-license agreement, the rights to which are held by Digene and Roche.
The 1990 cross-license agreement was struck between Digene predecessor Life Technologies and Roche predecessor the Pasteur Institute.
Digene said it filed for the arbitration in December 2006, saying that Roche had transferred to Gen-Probe human papillomavirus products under “the guise of a supply and purchase agreement,” Digene said.
The American Arbitration Association’s International Center for Dispute Resolution in New York is arbitrating the case.